JP2008538589A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538589A5
JP2008538589A5 JP2008507201A JP2008507201A JP2008538589A5 JP 2008538589 A5 JP2008538589 A5 JP 2008538589A5 JP 2008507201 A JP2008507201 A JP 2008507201A JP 2008507201 A JP2008507201 A JP 2008507201A JP 2008538589 A5 JP2008538589 A5 JP 2008538589A5
Authority
JP
Japan
Prior art keywords
pla
micelles
drug
pmhla
encapsulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008507201A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538589A (ja
JP5749881B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/002849 external-priority patent/WO2007012979A2/en
Publication of JP2008538589A publication Critical patent/JP2008538589A/ja
Publication of JP2008538589A5 publication Critical patent/JP2008538589A5/ja
Application granted granted Critical
Publication of JP5749881B2 publication Critical patent/JP5749881B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008507201A 2005-04-22 2006-04-21 ポリラクチド組成物およびその使用 Expired - Fee Related JP5749881B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US67410305P 2005-04-22 2005-04-22
US60/674,103 2005-04-22
US75014105P 2005-12-14 2005-12-14
US60/750,141 2005-12-14
PCT/IB2006/002849 WO2007012979A2 (en) 2005-04-22 2006-04-21 Polylactide compositions and uses thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2013243625A Division JP2014065722A (ja) 2005-04-22 2013-11-26 ポリラクチド組成物およびその使用
JP2014207007A Division JP6346540B2 (ja) 2005-04-22 2014-10-08 ポリラクチド組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2008538589A JP2008538589A (ja) 2008-10-30
JP2008538589A5 true JP2008538589A5 (https=) 2014-01-16
JP5749881B2 JP5749881B2 (ja) 2015-07-15

Family

ID=37603048

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2008507201A Expired - Fee Related JP5749881B2 (ja) 2005-04-22 2006-04-21 ポリラクチド組成物およびその使用
JP2013243625A Pending JP2014065722A (ja) 2005-04-22 2013-11-26 ポリラクチド組成物およびその使用
JP2014207007A Expired - Fee Related JP6346540B2 (ja) 2005-04-22 2014-10-08 ポリラクチド組成物およびその使用
JP2016051888A Expired - Fee Related JP6491614B2 (ja) 2005-04-22 2016-03-16 ポリラクチド組成物およびその使用
JP2017176282A Expired - Fee Related JP6559198B2 (ja) 2005-04-22 2017-09-14 ポリラクチド組成物およびその使用

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2013243625A Pending JP2014065722A (ja) 2005-04-22 2013-11-26 ポリラクチド組成物およびその使用
JP2014207007A Expired - Fee Related JP6346540B2 (ja) 2005-04-22 2014-10-08 ポリラクチド組成物およびその使用
JP2016051888A Expired - Fee Related JP6491614B2 (ja) 2005-04-22 2016-03-16 ポリラクチド組成物およびその使用
JP2017176282A Expired - Fee Related JP6559198B2 (ja) 2005-04-22 2017-09-14 ポリラクチド組成物およびその使用

Country Status (9)

Country Link
US (5) US8466133B2 (https=)
EP (2) EP3339348B1 (https=)
JP (5) JP5749881B2 (https=)
CA (1) CA2605652C (https=)
DK (1) DK1883665T3 (https=)
ES (1) ES2646141T3 (https=)
PL (1) PL1883665T3 (https=)
PT (1) PT1883665T (https=)
WO (1) WO2007012979A2 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466133B2 (en) * 2005-04-22 2013-06-18 University Of Geneva Polylactides compositions and uses thereof
WO2008121702A2 (en) * 2007-03-28 2008-10-09 Boston Scientific Scimed, Inc. Medical devices having bioerodable layers for the release of therapeutic agents
US20100159011A1 (en) * 2007-08-03 2010-06-24 University Of Massachusetts Medical School Compositions For Biomedical Applications
US8697098B2 (en) * 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
CN101665566B (zh) * 2008-09-01 2012-01-04 南京工业大学 一种利用双螺杆挤出机制备聚乳酸及其制品的方法
FR2942800B1 (fr) * 2009-03-06 2012-04-20 Minasolve Procede de polymerisation par voie catalytique de 1,4-dioxanes-2,5 diones et les polymeres correspondants
WO2011082479A1 (en) * 2010-01-08 2011-07-14 University Of Prince Edward Island Star polymers having controlled tacticity and methods of making same
DK2598553T3 (da) 2010-07-26 2016-08-01 Univ Geneve Sammensætninger omfattende polymerer fremstillede af 2-hydroxyalkylsyrer
BR112013021732B1 (pt) 2011-02-25 2021-11-30 South Dakota State University Micela estável e utilização da micela estável
US20140335135A1 (en) * 2011-12-05 2014-11-13 Ferring Bv Pharmaceutical composition
JP6184982B2 (ja) * 2012-02-02 2017-08-23 エスバテック − ア ノバルティス カンパニー エルエルシー 点眼用抗体含有徐放性製剤
AR092821A1 (es) * 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
AR090736A1 (es) * 2012-04-20 2014-12-03 Sucampo Ag Conjugado de compuesto triciclo-polimero
WO2014122294A1 (en) * 2013-02-08 2014-08-14 Total Research & Technology Feluy Process for preparing cyclic esters and cyclic amides
US9080012B2 (en) * 2013-07-10 2015-07-14 Xerox Corporation One-pot, neat ring opening polymerization to prepare resin
US8975344B2 (en) * 2013-07-10 2015-03-10 Xerox Corporation Polyester/polycarbonate block copolymers via one-pot, neat ring opening polymerization
DE102013018193A1 (de) 2013-10-30 2015-05-13 Martin-Luther-Universität Halle-Wittenberg, Körperschaft des öffentlichen Rechts Injizierbare Depotformulierungen zur kontrollierten Wirkstofffreisetzung
US9999704B2 (en) * 2014-02-26 2018-06-19 University Of Massachusetts Amphiphilic degradable polymers for immobilization and sustained delivery of biomolecules
DE102014005782A1 (de) 2014-04-23 2015-10-29 Martin-Luther-Universität Halle-Wittenberg lnjizierbare und implantierbare Trägersysteme auf Basis von modifizierten Poly(dikarbonsäure-multiol estern) zur kontrollierten Wirkstofffreisetzung
JP6557722B2 (ja) 2014-05-30 2019-08-07 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 核酸の送達のための生分解性脂質
WO2016079416A1 (fr) * 2014-11-17 2016-05-26 Roquette Freres Composition à base d'amidon thermoplastique et de polyester aliphatique
US9603975B2 (en) * 2014-12-16 2017-03-28 Boston Scientific Scimed, Inc. Bioerodible polymer compositions
US9260550B1 (en) 2015-01-27 2016-02-16 International Business Machines Corporation Lactide-based acrylate polymers
JP6148701B2 (ja) * 2015-07-31 2017-06-14 ユニベルシテ ドゥ ジュネーブ ２−ヒドロキシアルキル酸から調製されたポリマーを含む組成物
US10035877B1 (en) 2017-03-08 2018-07-31 International Business Machines Corporation Matrix-bondable lactide monomors for polylactide synthesis
US10072121B1 (en) 2017-03-08 2018-09-11 International Business Machines Corporation Bottlebrush polymers derived from poly(methylidenelactide)
US10570252B2 (en) 2017-03-08 2020-02-25 International Business Machines Corporation Flame retardant lactide monomors for polylactide synthesis
US10202489B2 (en) 2017-03-08 2019-02-12 International Business Machines Corporation Lactide copolymers and ring-opened lactide copolymers
EP3743041A1 (en) 2018-01-26 2020-12-02 Apidel SA New spironolactone formulations and their use
CA2994005A1 (fr) 2018-02-05 2019-08-05 Hydro-Quebec Copolymeres d'unites ester et ether, leurs procedes de fabrication et leurs utilisations
EP3656378A1 (en) * 2018-11-26 2020-05-27 ValMeyer Sàrl New composition of amide and ester local anesthetics and uses thereof
US11407855B2 (en) 2019-08-23 2022-08-09 The Board Of Trustees Of The University Of Illinois Ring opening polymerization in an aqueous dispersion
CN116217900B (zh) * 2021-12-02 2025-12-30 惠生工程（中国）有限公司 一种乙交酯、丙交酯开环共聚合制备pgla的装置及工艺
WO2024064758A2 (en) * 2022-09-21 2024-03-28 Hercules Llc Coating composition comprising a bioresorbable copolymer and an anti-microbial agent

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
US5725871A (en) 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
US5707644A (en) 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
WO1993000077A1 (en) 1991-06-21 1993-01-07 University Of Cincinnati Orally administrable therapeutic proteins and method of making
US5756353A (en) 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
CA2087125A1 (en) * 1992-01-23 1993-07-24 Mridula Nair Chemically fixed micelles
US5573934A (en) 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5686630A (en) * 1993-09-29 1997-11-11 Chronopol, Inc. Purifying cyclic esters by aqueous solvent extraction
ES2105262T3 (es) 1992-05-18 1997-10-16 Minnesota Mining & Mfg Dispositivo de suministro de farmaco a traves de las mucosas.
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
KR970002523B1 (en) * 1993-04-24 1997-03-05 Korea Inst Sci & Tech Biodegradable polylactic acid having improved properties and method for manufacturing the same
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5580579A (en) 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6451346B1 (en) 1998-12-23 2002-09-17 Amgen Inc Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
US6469133B2 (en) * 1999-12-13 2002-10-22 Board Of Trustees Of Michigan State University Process for the preparation of polymers of dimeric cyclic esters
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
KR100484371B1 (ko) 2001-10-25 2005-04-20 가부시키가이샤 아텍스 히터선부착 시트체의 제조방법
DE60333566D1 (de) * 2002-08-13 2010-09-09 Medtronic Inc Medizinische vorrichtung mit verbesserter haftung zwischen einem polymeren berzug und einem substrat
KR20050084599A (ko) * 2002-09-26 2005-08-26 안지오테크 인터내셔날 아게 혈관주위 랩
US7533176B2 (en) 2004-07-14 2009-05-12 International Business Machines Corporation Method for supporting connection establishment in an offload of network protocol processing
US8466133B2 (en) * 2005-04-22 2013-06-18 University Of Geneva Polylactides compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP2008538589A5 (https=)
Danafar Study of the composition of polycaprolactone/poly (ethylene glycol)/polycaprolactone copolymer and drug-to-polymer ratio on drug loading efficiency of curcumin to nanoparticles
Zhang et al. Camptothecin derivative-loaded poly (caprolactone-co-lactide)-b-PEG-b-poly (caprolactone-co-lactide) nanoparticles and their biodistribution in mice
Liu et al. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly (N-isopropylacrylamide-co-N, N-dimethylacrylamide)-b-poly (D, L-lactide-co-glycolide) with varying compositions
Tao et al. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy
Trimaille et al. Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly (hexyl-substituted lactides)
Cammas et al. Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the design of biocompatible hydrolyzable devices
Prabaharan et al. Amphiphilic Multi‐Arm Block Copolymer Based on Hyperbranched Polyester, Poly (l‐lactide) and Poly (ethylene glycol) as a Drug Delivery Carrier
Zhang et al. Methotrexate-loaded biodegradable polymeric micelles: preparation, physicochemical properties and in vitro drug release
Cao et al. Effect of architecture on the micellar properties of poly (ɛ-caprolactone) containing sulfobetaines
WO2001085216A1 (en) Method for the preparation of polymeric micelle via phase separation of block copolymer
AU2001258872A1 (en) Method for the preparation of polymeric micelle via phase separation of block copolymer
Xie et al. Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-β-cyclodextrin inoculations
CA2709993A1 (en) Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same
Nguyen et al. Reverse micelles prepared from amphiphilic polylactide-b-poly (ethylene glycol) block copolymers for controlled release of hydrophilic drugs
EP1539109B1 (en) Block copolymer micelle composition having an enhanced drug-loading capacity and sustained release
KR101964222B1 (ko) 미셀 안정성이 향상된 양친성 블록 공중합체 조성물 및 이를 포함하는 약학 조성물
Jäger et al. Novel “soft” biodegradable nanoparticles prepared from aliphatic based monomers as a potential drug delivery system
NZ543001A (en) Biodegradable branched polylactide derivatives capable of forming polymeric micelles, and their preparation method and use
Cha et al. Stabilized polymeric micelles by electrostatic interactions for drug delivery system
Jin et al. Novel amphiphilic, biodegradable, biocompatible, cross-linkable copolymers: synthesis, characterization and drug delivery applications
Sun et al. Self‐assembled micelles prepared from poly (ɛ‐caprolactone)–poly (ethylene glycol) and poly (ɛ‐caprolactone/glycolide)–poly (ethylene glycol) block copolymers for sustained drug delivery
Khoee et al. Effects of hydrophobic drug–polyesteric core interactions on drug loading and release properties of poly (ethylene glycol)–polyester–poly (ethylene glycol) triblock core–shell nanoparticles
Yang et al. In vitro degradation behavior of poly (lactide)–poly (ethylene glycol) block copolymer micelles in aqueous solution
Xu et al. Comparative study of paclitaxel physically encapsulated in and chemically conjugated with PEG‐PLA